Early studies identified a role for the melanoma survival gene MITF as a mediator of non-mutational and reversible drug tolerance [59], which has been characterised by proliferative to invasive phenotype switching [60], altered mitochondrial metabolism [43,55], and adaptive starvation responses [61]. The gene discussed is MITF; the disease is melanoma.